U.S. House · 119th Congress · H.R. 9699
Drug Deal Disclosure Act
To require the Department of Health and Human Services to release documents, communications, and other information relating to most favored nation pricing agreements and other private or confidential drug pricing deals struck with manufacturers, and for other purposes.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Judy ChuD-CA-28
- Introduced
- July 15, 2026, in the House
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (24)
24 Democrats. Each member is shown with the party they were counted with on the day they signed on. How we count these
Original cosponsors
- Donald S. Beyer, Jr.D-VA-8
- André CarsonD-IN-7
- Kathy CastorD-FL-14
- Yvette D. ClarkeD-NY-9
- Suzan K. DelBeneD-WA-1
- Maxine DexterD-OR-3
- Lloyd DoggettD-TX-37
- Dwight EvansD-PA-3
- Maggie GoodlanderD-NH-2
- Summer L. LeeD-PA-12
- Doris O. MatsuiD-CA-7
- Betty McCollumD-MN-4
- Kweisi MfumeD-MD-7
- Gwen MooreD-WI-4
- Eleanor Holmes NortonD-DC-AL
- Jimmy PanettaD-CA-19
- Chris PappasD-NH-1
- Deborah K. RossD-NC-2
- Janice D. SchakowskyD-IL-9
- Bradley Scott SchneiderD-IL-10
- Mark TakanoD-CA-39
- Rashida TlaibD-MI-12
- Nikema WilliamsD-GA-5
Signed on later
- Paul TonkoD-NY-20July 16, 2026